PharmaShots | Incisive News in 3 Shots

Subscribe Now

Decitabine

AbbVie's Venclyxto Receives the EC's Approval for Patients with Newly Diagnosed Acute Myeloid Leukemia who are Ineligible for Intensive Chemotherapy

AbbVie's Venclyxto Receives the EC's Approval for Patients with Newly Diagnosed Acute Myeloid Leukemia who are Ineligible for Inte...

May 26, 2021

Otsuka Inqovi (decitabine and cedazuridine) Received the US FDA's Approval to MDS and CMML

Otsuka Inqovi (decitabine and cedazuridine) Received the US FDA's Approval to MDS and CMML

July 20, 2020

Genentech's Venclexta (venetoclax) Receives FDA's Accelerated Approval for Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML)

Genentech's Venclexta (venetoclax) Receives FDA's Accelerated Approval for Patients with Newly-Diagnosed Acute Myeloid Leukemia (A...

November 22, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us